Iveric Bio

Developer of gene therapy solutions to treat retinal diseases

placeNew York City, New York, United States calendar_todayFounded 2007 groups94 employees language ivericbio.com

Registered entities

Innovation

7 patent families (3 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace slowing. Cited 1,867 times.

YearFilings
20151
20161
20192
20202
20213
20224
20234
20246
20251

Investor mix

5 investors on record; 2 have since exited.

Investor typeCountShare
Venture capital240%
Private equity240%
Other / undisclosed120%
Coming soon